IRIS
DI MARIO, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.365
AS - Asia 24.432
EU - Europa 14.611
SA - Sud America 3.760
AF - Africa 1.372
Continente sconosciuto - Info sul continente non disponibili 64
OC - Oceania 54
Totale 71.658
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.668
SG - Singapore 10.096
CN - Cina 8.159
IE - Irlanda 3.627
SE - Svezia 3.301
BR - Brasile 3.003
HK - Hong Kong 1.818
TR - Turchia 1.489
VN - Vietnam 1.488
DE - Germania 1.337
UA - Ucraina 1.241
FI - Finlandia 1.199
ZA - Sudafrica 964
IT - Italia 950
NL - Olanda 941
RU - Federazione Russa 556
GB - Regno Unito 489
CA - Canada 452
AR - Argentina 294
IN - India 290
FR - Francia 195
CI - Costa d'Avorio 177
BD - Bangladesh 174
BE - Belgio 149
MX - Messico 142
IQ - Iraq 131
EC - Ecuador 126
PL - Polonia 113
ID - Indonesia 107
AT - Austria 105
JP - Giappone 101
CO - Colombia 82
ES - Italia 72
UZ - Uzbekistan 62
VE - Venezuela 62
PK - Pakistan 61
EU - Europa 59
PY - Paraguay 58
KR - Corea 57
LT - Lituania 55
MA - Marocco 55
AU - Australia 50
CL - Cile 50
IR - Iran 48
RO - Romania 47
EG - Egitto 43
CZ - Repubblica Ceca 39
KE - Kenya 38
AE - Emirati Arabi Uniti 37
SA - Arabia Saudita 35
IL - Israele 33
PE - Perù 32
HU - Ungheria 29
UY - Uruguay 28
BG - Bulgaria 27
TN - Tunisia 27
AZ - Azerbaigian 26
DZ - Algeria 23
JO - Giordania 22
BO - Bolivia 21
CR - Costa Rica 20
PA - Panama 19
MY - Malesia 18
KG - Kirghizistan 16
LB - Libano 15
PH - Filippine 15
AL - Albania 14
DO - Repubblica Dominicana 14
JM - Giamaica 14
KZ - Kazakistan 14
NP - Nepal 13
PT - Portogallo 13
RS - Serbia 13
SK - Slovacchia (Repubblica Slovacca) 13
TW - Taiwan 13
CH - Svizzera 11
HR - Croazia 11
BY - Bielorussia 10
OM - Oman 10
BH - Bahrain 9
LV - Lettonia 9
SN - Senegal 9
GE - Georgia 8
HN - Honduras 8
LK - Sri Lanka 8
MD - Moldavia 8
TT - Trinidad e Tobago 8
AM - Armenia 7
ET - Etiopia 7
GR - Grecia 7
KH - Cambogia 7
TH - Thailandia 7
EE - Estonia 6
PS - Palestinian Territory 6
BN - Brunei Darussalam 5
KW - Kuwait 5
LU - Lussemburgo 5
NO - Norvegia 5
XK - ???statistics.table.value.countryCode.XK??? 5
CG - Congo 4
Totale 71.569
Salva come PNG Salva come JPEG
Città #
Chandler 4.808
Singapore 4.605
Dublin 3.617
Ashburn 2.990
Santa Clara 2.150
Hong Kong 1.802
Beijing 1.776
Dearborn 1.619
Nanjing 1.316
Izmir 1.236
Jacksonville 1.222
Boardman 1.015
Dallas 996
Johannesburg 915
Princeton 831
Ho Chi Minh City 616
New York 571
Shanghai 511
Wilmington 464
San Mateo 446
Munich 434
Moscow 431
Los Angeles 426
Helsinki 417
Ann Arbor 399
Shenyang 379
Nanchang 360
Columbus 323
Hanoi 318
Hebei 297
Toronto 284
São Paulo 258
Tianjin 248
Kunming 243
Jinan 227
Changsha 225
Hefei 220
Jiaxing 203
Kocaeli 174
Parma 173
Abidjan 170
Buffalo 160
Guangzhou 141
The Dalles 133
Brussels 131
Norwalk 131
Seattle 124
Hangzhou 120
Chicago 114
Turku 106
Zhengzhou 103
Frankfurt am Main 94
Fremont 92
London 90
Pune 89
Tokyo 87
Rio de Janeiro 83
Warsaw 83
Brooklyn 80
Council Bluffs 74
Vienna 74
Des Moines 72
Bremen 70
Houston 69
Ningbo 67
Stockholm 67
Montreal 66
Belo Horizonte 65
Denver 63
Milan 61
Nuremberg 59
Boston 54
Porto Alegre 54
Atlanta 53
Haiphong 53
Biên Hòa 51
Phoenix 51
Tashkent 51
Woodbridge 51
Chennai 50
Baghdad 49
San Francisco 49
Washington 47
Curitiba 46
Da Nang 45
Brasília 42
Quito 42
Campinas 41
Rome 39
Seoul 39
Grafing 38
Dhaka 37
Taizhou 37
Bologna 35
Poplar 35
Wuhan 35
Edinburgh 34
Hải Dương 34
Nairobi 34
Cambridge 33
Totale 43.742
Salva come PNG Salva come JPEG
Nome #
CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE 255
5 OP Keratin 8 gene mutation in patients with chronic pancreatitis 193
Studio della lattoferrina nel succo pancreatico-duodenale. Limiti nelle diagnosi di pancreatite cronica 178
Low Levels of Gastrin 17 are Related with Endoscopic Findings of Esophagitis and Typical Symptoms of GERD 170
Coffee intake and gastroesophageal reflux: Relationship with clinical, endoscopic and functional features 168
Recovery of gastric function in patients affected by chronic atrophic gastritis using L-cysteine (Acetium®): one year survey in comparison with a control group 167
Approach to gastroenterological diseases in primary care 157
Eosinophilic esophagitis in pediatric age, state of the art and review of the literature 152
Burning Mouth Syndrome Etiology: A Narrative Review 151
Associations of spink-1 (N345) and PRSS-1 (N29I AND R122H) gene mutations and chronic pancreatitis in Italy 146
A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure? 145
Advanced gastric cancer: the value of systemic and intraperitoneal chemotherapy 145
Thyroid and celiac disease in pediatric age: a literature review 145
Long-term treatment for gastric and duodenal ulcer 144
W1079 Curcumin Vs Domperidon in Functional Dyspepsia: Better the Prokinetic or An Agonist of Vanilloid Receptor? 144
Endoscopic ultrasound in pediatric population: a comprehensive review of the literature 143
Is it possible to withdrawal PPI’s therapy in GERD patients? A prospective study on 216 patients using HYCHSA 142
Advanced gastric cancer: the value of surgery 141
710 Gastrin-17 (G-17): A Serological Bio-Marker for Diagnosis of Gastro-Esophageal Reflux Disease (GERD) 138
Clinical markers of slow healing and relapsing gastric ulcer 137
Autonomic balance in inflammatory bowel diseases, irritable bowel syndrome and gastroesophageal reflux disease 136
[Cisapride and sucralfate in dyspepsia associated with duodenogastric reflux gastritis] 136
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy 136
7 P Frequency of CFTR gene mutations in consecutive patients suffering from chronic pancreatitis 135
Barrett’s esophagus: results from an Italian cohort with tight endoscopic surveillance 134
Hemolytic uremic syndrome: differential diagnosis with the onset of inflammatory bowel diseases 133
Acid-related disorders in the elderly 132
42 OP Potential use of lactoferrin in a 7 days triple therapy for helicobacter pylori eradication: A pilot study 132
Growth changes after gluteen free diet in pediatric celiac patients: a literature-review 132
Conservative treatment of acute appendicitis 131
Cure of Helicobacter pylori infection in the elderly: effects of eradication on gastritis and serological markers 131
Accuracy of “serological gastric biopsy” in a cohort of dyspeptic patients 130
Association of HLA-DRB1 *0401 Allele with chronic pancreatitis 130
Cimetidine, ranitidine, and pirenzepine in the treatment of duodenal ulcer: A six-month low-dose treatment period followed by a six-month observation period 130
Risk of tumor implantation in percutaneous endoscopic gastrostomy in the upper aerodigestive tumors 130
How and when investigating and treating Helicobacter pylori infection in children 130
Inverse association between Helicobacter pylori and inflammatory bowel disease: myth or fact? 130
CONNECTIONS BETWEEN GENETICS ANCùD CLINICAL DATA:ROLE OF MCP-1 , CFTR AND SPINK-1 IN THE CLINICAL SETTING OF ACUTE,ACUTE RECURRENT AND CHRONIC PANCREATITIS. 129
Individualized treatment of duodenal ulcer disease. A pilot study 129
Association of keratin 8 gene mutation with chronic pancreatitis 128
T1082 Eradication Rate of Helicobacter pylori in Immigrant Patients Compared to Italian Patients: Results of a Clinical Trial 128
RANITIDINA E NIZATIDINA NELL'ULCERA PEPTICA DELL'ANZIANO: STUDIO MULTICENTRICO, IN DOPPIO CIECO, A BREVE TERMINE 128
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer] 128
Gastric function assessed by Gastropanel in very old patients (over 80 years old) and appropriateness of PPIs administration 127
ASPETTI METODOLOGICI DEL SONDAGGIO GASTRICO 127
P.08.9: The Early Diagnosis of Gastric Cancer: A Six Years Survey Based on 584 Surgical Specimen in Parma Area 127
'Serological biopsy' in first-degree relatives of patients with gastric cancer affected by Helicobacter pylori infection 126
Epithelial dysplasia in atrophic gastritis. Bioptical follow-up study 126
Clinical Trends and Burden of Death in Gastric Cancer: A Six Years Survey 126
S1921 “GastroPanel Test” in the Clinical Outcome of GERD 126
Comparison of three different therapeutic regimens for eradicating Helicobacter pylori 126
Quality of life in uncomplicated diverticular disease: Is it another good reason for the treatment? 125
Serum pepsinogen II for early assessment of success of H. pylori eradication 125
Gastric and duodenal ulcer in the same patient 125
[Clinical usefulness of endoscopy of the upper digestive tract in the aged] 125
[Clinical usefulness of the blood gastrin curve after protein meal in duodenal ulcer] 124
Biochemical and histopathological aspects in duodenogastric reflux gastritis patients with or without prior cholecystectomy 124
S1808 Connections Between Genetics and Clinical Data: Role of MCP-1, CFTR and SPINK-1 in the Clinical Setting of Acute, Acute Recurrent and Chronic Pancreatitis 124
10 Day bismuth-based quadruple therapy for HP eradication in comparison with other therapies in a population with high clarithromycin resistance in northeast Italy 123
P.1.193: MESALAMINE FOR THE MANAGEMENT OF PATIENTS WITH UNCOMPLICATED DIVERTICULAR DISEASE (SUDD): A 24 MONTHS PROSPECTIVE FOLLOW-UP STUDY 123
Bovine lactoferrin as a rescure treatment for Helicobacter pylori infection: results of a multicenter study 122
ACID SUPPRESSION THERAPY: WHERE DO WE FROM HERE? 122
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. 122
A symptom-orientated PPI strategy in the treatment of the ENT manifestations of GERD. 122
P.02.8: Chronic Atrophic Gastritis is Related with an Increased Risk for Cardiovascular Diseases, Assessed by Homocysteine Serum Levels Determination 122
Accumulation, platinum-DNA adduct formation and cytotoxicity of cisplatin, oxaliplatin and satraplatin in sensitive and resistant human osteosarcoma cell lines, characterized by p53 wild-type status 122
H2-blockers in the treatment of ulcer disease in the elderly 122
A non-invasive method for the diagnosis of upper GI diseases 122
THE SLEEPING REMNANT 120
[Ca 19-9 in the diagnosis of pancreatic carcinoma] 120
P.154 CONNECTIONS BETWEEN GENETICS AND CLINICAL DATA: ROLE OF MCP-1, CFTR, AND SPINK-1 IN THE SETTING OF ACUTE, ACUTE RECURRENT, AND CHRONIC PANCREATITIS 119
Cure of Helicobacter pylori-positive active duodenal ulcer patients: a double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy. GISU (Interdisciplinary Group for Ulcer Study) 119
Cure of Helicobacter pylori-positive active duodenal ulcer patients: double-blind, multicentre, 12-month study comparing a two-week dual vs a one-week triple therapy 119
P.29 USEFULNESS OF NON INVASIVE TEST (GASTROPANEL) FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASE 119
Is the risk of contrast-induced nephropathy a real contraindication to perform intravenous contrast enhanced Computed Tomography for non-traumatic acute abdomen in Emergency Surgery Department? 119
INFLUENCE OF BMI ON GASTRIC ACID SECRETION IN ACID RELATED DISEASE 119
Cancer adenomas founbd during 15 years of screening in the Alto Vicentino area (north-east Italy) 119
Does chronic hypercalcemia influence serum pepsinogens levels? 118
OC1.09.3 USEFULNESS OF GASTROPANEL FOR SCREENING OF ATROPHIC GASTRITIS IN PATIENTS WITH AUTOIMMUNE THYROID DISEASES 118
Gastrin 17 in Singling Out Patients with Different Patterns of Refluxate: A Pilot Study Using Impedance-pH as Reference Standard 118
P.1.288: PEPSINOGEN I, II, RATIO, AND G-17 IN PATIENTS WITH ESOPHAGITIS AND PATIENTS WITH EXTRA-ESOPHAGEAL MANIFESTATIONS OF GERD 118
Rabepmzole in the treatment of non-responders GERD patients: a prospective six-month study 118
Epidemiology and risk factors for diverticular disease 118
Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study. 117
P.01.13: Gastrin-17 as a Non-Invasive Marker for Gerd: A Prospective Study on Sample of 777 Consecutive Patients 117
Compliance with therapy for ulcer disease: clinical experience and review of the literature 117
Epidemiology and risk factors of pancreatic cancer 117
800 mg of cimetidine versus 300 mg of ranitidine at bedtime in the short-term treatment of duodenal ulcer: A cost/benefit study 117
PA.28 SERUM PEPSINOGEN I AS NON INVASIVE MARKER OF GASTRIC ACID SECRETION 117
P.02.5: PPI Test for Diagnosis of Body Atrophic Gastritis: A Prospective Study 117
Azithromycin for the cure of Helicobacter pylori infection 117
Associations of Spink-1 (N34S) and PRSS-1 (N29I and R122H) gene mutations and chronic pancreatitis in Italy 116
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015 116
Usefulness of Serum Pepsinogens to Identify Chronic Atrophic Gastritis 116
Impact of treatments on fecal microbiota and fecal metabolome in symptomatic uncomplicated diverticular disease of the colon 116
Gastro panel® for detection of atrophic gastritis: The “Parma model” 116
M1695 Serum Pepsinogens and Topography of Chronic Atrophic Gastritis in a Population Sample Referred for Endoscopy 116
[Alcohol-dependent mast cell activation in ulcer] 116
CARATTERISTICHE EPIDEMIOLOGICHE, CLINICHE E FUNZIONALI IN PAZIENTI CON SANGUINAMENTO DA ULCERA DUODENALE 116
Microsatellite instability in colorectal cancer 116
Totale 13.045
Salva come PNG Salva come JPEG
Categoria #
all - tutte 272.847
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 272.847
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.412 0 0 0 0 0 49 260 11 431 235 372 54
2021/20223.602 47 23 52 224 206 59 213 444 176 310 342 1.506
2022/202314.711 1.540 1.337 984 1.304 1.153 1.798 103 1.127 4.622 60 555 128
2023/20244.820 251 577 136 136 414 1.364 214 351 145 282 398 552
2024/202516.639 347 988 1.140 853 1.997 1.879 504 660 2.511 1.562 1.396 2.802
2025/202617.499 3.017 3.075 3.337 2.646 4.984 440 0 0 0 0 0 0
Totale 72.389